Lupin Launches Generic Dapagliflozin and Metformin Tablets in US
1 hour agoBusiness
32LENS
3 SourcesNew Delhi, India
TBNthebalanced.news

Lupin Launches Generic Dapagliflozin and Metformin Tablets in US

Pharma company Lupin Ltd has launched its generic version of the anti-diabetic medicine dapagliflozin and metformin hydrochloride extended-release tablets in the US. The launch follows approval from the US Food and Drug Administration (USFDA), confirming the drug's bioequivalence to Xigduo XR. The tablets are available in strengths of 5 mg/500 mg, 5 mg/1,000 mg, 10 mg/500 mg, and 10 mg/1,000 mg, according to Lupin's regulatory filing.

Political Bias
0%100%0%
Sentiment
68%
AI analysis of 3 sources · Published under editorial oversight by The Balanced News
Analysed 22 Apr 2026· How this analysis is produced· Editorial standards· Corrections

AI Analysis

Political bias across 3 sources
● Left 0%● Center 100%● Right 0%

The articles present a straightforward business and regulatory update without political framing. Coverage focuses on Lupin's product launch and USFDA approval, reflecting corporate and regulatory perspectives. There is no evident political bias or partisan interpretation in the reporting.

Sentiment — Positive (68/100)

The tone across the articles is neutral and factual, emphasizing the regulatory approval and product launch. There is no positive or negative sentiment expressed beyond the informative announcement of Lupin's market entry.

How 3 sources covered this story

Each source's own headline, political lean, and sentiment — so you can see framing differences at a glance.

SourceTheir headlineBiasSentiment
businessstandardLupin launches diabetes drug in U.S. after FDA nodCenterPositive
economictimesLupin launches generic anti-diabetic tablets in USCenterNeutral
news18Lupin launches generic anti-diabetic tablets in USCenterNeutral

Coverage timeline

news18 broke this story on 22 Apr, 05:35 am. Other outlets followed.

  1. 1
    news1822 Apr, 05:35 am
    Lupin launches generic anti-diabetic tablets in US
  2. 2
    economictimes22 Apr, 06:32 am
    Lupin launches generic anti-diabetic tablets in US
  3. 3
    businessstandard22 Apr, 06:54 am
    Lupin launches diabetes drug in U.S. after FDA nod

Lens Score breakdown

32/100
Public interest0/100
Coverage gap100%

Well-covered story — coverage matches public importance.

Who's involved

Institutions and figures named across source coverage.

Government
US Food and Drug Administration
Corporate
Lupin LtdUS Food and Drug Administration

Story context

Category
Business
Location
New Delhi, India
Sources analysed
3
Last analysed
22 Apr 2026
Key entities
Tablet (pharmacy)DapagliflozinMetforminGeneric drugFood and Drug AdministrationHydrochlorideModified-release dosageNew DelhiMedicineNew drug applicationBioequivalenceLupin Limited